| 000 | 01546 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514162542.0 | ||
| 264 | 0 | _c20040907 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0143-3636 | ||
| 024 | 7 |
_a10.1097/00006231-200312000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaglar, M | |
| 245 | 0 | 0 |
_aFrequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? _h[electronic resource] |
| 260 |
_bNuclear medicine communications _cDec 2003 |
||
| 300 |
_a1231-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTechnetium Tc 99m Medronate |
| 700 | 1 | _aCeylan, E | |
| 700 | 1 | _aOzyar, E | |
| 773 | 0 |
_tNuclear medicine communications _gvol. 24 _gno. 12 _gp. 1231-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006231-200312000-00005 _zAvailable from publisher's website |
| 999 |
_c14364420 _d14364420 |
||